OTC Pharmaceuticals in the Netherlands

"Datamonitor’s OTC Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Table of Contents
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Market Share 12
CHAPTER 6 Five Forces Analysis 13
6.1 Summary 13
6.2 Buyer Power 14
6.3 Supplier Power 15
6.4 New Entrants 16
6.5 Substitutes 18
6.6 Rivalry 19
CHAPTER 7 Leading Companies 20
7.1 Bayer AG 20
7.2 Pfizer Inc 23
7.3 Procter & Gamble Company, The 25
CHAPTER 8 Distribution 28
CHAPTER 9 Market Forecasts 29
9.1 Market Value Forecast 29
CHAPTER 10 Macroeconomic Indicators 30
CHAPTER 11 Appendix 32
11.1 Methodology 32
11.2 Industry Associations 33
11.3 Related Datamonitor Research 33

LIST OF TABLES
Table 1: Netherlands OTC Pharmaceuticals Market Value: $ million, 2003-2007 9
Table 2: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10
Table 3: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11
Table 4: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007 12
Table 5: Key Facts: Bayer AG 20
Table 6: Key Financials: Bayer AG 22
Table 7: Key Facts: Pfizer Inc 23
Table 8: Key Financials: Pfizer Inc 24
Table 9: Key Facts: Procter & Gamble Company, The 25
Table 10: Key Financials: Procter & Gamble Company, The 27
Table 11: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2007 28
Table 12: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2007-2012 29
Table 13: Netherlands Size of Population (million) , 2003-2007 30
Table 14: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 30
Table 15: Netherlands Inflation, 2003-2007 30
Table 16: Netherlands Exchange Rate, 2003 31

"